- Home
- BNR vs HBIO Comparison
BNR vs HBIO Comparison
Compare BNR & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- HBIO
- Stock Information
- Founded
- BNR 2014
- HBIO 1901
- Country
- BNR China
- HBIO United States
- Employees
- BNR N/A
- HBIO N/A
- Industry
- BNR Medical Specialities
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- BNR Health Care
- HBIO Industrials
- Exchange
- BNR Nasdaq
- HBIO Nasdaq
- Market Cap
- BNR 61.7M
- HBIO 61.2M
- IPO Year
- BNR 2020
- HBIO 2000
- Fundamental
- Price
- BNR $5.66
- HBIO $0.82
- Analyst Decision
- BNR
- HBIO
- Analyst Count
- BNR 0
- HBIO 0
- Target Price
- BNR N/A
- HBIO N/A
- AVG Volume (30 Days)
- BNR 5.3K
- HBIO 313.7K
- Earning Date
- BNR 03-27-2025
- HBIO 05-06-2025
- Dividend Yield
- BNR N/A
- HBIO N/A
- EPS Growth
- BNR N/A
- HBIO N/A
- EPS
- BNR N/A
- HBIO N/A
- Revenue
- BNR $72,832,704.00
- HBIO $97,732,000.00
- Revenue This Year
- BNR $52.90
- HBIO N/A
- Revenue Next Year
- BNR $48.35
- HBIO $4.32
- P/E Ratio
- BNR N/A
- HBIO N/A
- Revenue Growth
- BNR N/A
- HBIO N/A
- 52 Week Low
- BNR $0.57
- HBIO $0.78
- 52 Week High
- BNR $8.99
- HBIO $4.70
- Technical
- Relative Strength Index (RSI)
- BNR 40.71
- HBIO 19.66
- Support Level
- BNR $4.41
- HBIO $1.26
- Resistance Level
- BNR $6.33
- HBIO $0.95
- Average True Range (ATR)
- BNR 0.54
- HBIO 0.09
- MACD
- BNR -0.16
- HBIO 0.00
- Stochastic Oscillator
- BNR 35.82
- HBIO 6.45
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.